ArticleThe British journal of radiology2024

Sorafenib plus transcatheter arterial chemoembolization with or without camrelizumab for the treatment of intermediate and advanced hepatocellular carcinoma.

Bo Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.